BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Travere Therapeutics to Participate at Upcoming Investor Conferences - November 4, 2025

  November 4, 2025

   · 

  1 min read
• Press Releases

  Gilead Sciences to Present at Upcoming Investor Conferences - November 4, 2025

  November 4, 2025

   · 

  1 min read
• Press Releases

  Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

  November 4, 2025

   · 

  18 min read
• Press Releases

  Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook

  November 4, 2025

   · 

  16 min read
• Press Releases

  OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

  November 4, 2025

   · 

  15 min read
• Press Releases

  Corcept Therapeutics Announces Third Quarter Financial Results, Oncology Development Programs and Provides Corporate Update

  November 4, 2025

   · 

  14 min read
• Press Releases

  Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

  November 4, 2025

   · 

  14 min read
• Press Releases

  Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results

  November 4, 2025

   · 

  10 min read
• Press Releases

  Eilean Therapeutics Presents First-in-Class MALT1 Degrader TE205 Demonstrating In Vivo Efficacy in Ulcerative Colitis at the 4th International Conference on Microbiology and Immunology

  November 4, 2025

   · 

  2 min read
• Press Releases

  Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update

  November 4, 2025

   · 

  16 min read